http://120.24.161.253:5617/index.php?action=history&feed=atom&title=%E8%83%B8%E8%85%94%E7%A7%AF%E6%B6%B2-%E5%AE%9E%E9%AA%8C%E5%AE%A4%E6%A3%80%E6%9F%A5-%E8%A1%80%E6%B8%85CEA 2026-05-04T03:49:19Z 本wiki的该页面的版本历史 MediaWiki 1.30.0 http://120.24.161.253:5617/index.php?title=%E8%83%B8%E8%85%94%E7%A7%AF%E6%B6%B2-%E5%AE%9E%E9%AA%8C%E5%AE%A4%E6%A3%80%E6%9F%A5-%E8%A1%80%E6%B8%85CEA&diff=1349000&oldid=prev 2024-07-06T14:00:00Z

<p>修改1</p> <table class="diff diff-contentalign-left" data-mw="interface"> <tr style="vertical-align: top;" lang="zh-CN"> <td colspan="1" style="background-color: white; color:black; text-align: center;">←上一版本</td> <td colspan="1" style="background-color: white; color:black; text-align: center;">2024年7月6日 (六) 14:00的版本</td> </tr><tr><td colspan="2" style="text-align: center;" lang="zh-CN"><div class="mw-diff-empty">（没有差异）</div> </td></tr></table>

Admin http://120.24.161.253:5617/index.php?title=%E8%83%B8%E8%85%94%E7%A7%AF%E6%B6%B2-%E5%AE%9E%E9%AA%8C%E5%AE%A4%E6%A3%80%E6%9F%A5-%E8%A1%80%E6%B8%85CEA&diff=1349001&oldid=prev 2024-07-06T09:47:20Z

<p>导入1个版本</p> <table class="diff diff-contentalign-left" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr style="vertical-align: top;" lang="zh-CN"> <td colspan="2" style="background-color: white; color:black; text-align: center;">←上一版本</td> <td colspan="2" style="background-color: white; color:black; text-align: center;">2024年7月6日 (六) 09:47的版本</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l7" >第7行：</td> <td colspan="2" class="diff-lineno">第7行：</td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>==来源==</div></td><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>==来源==</div></td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>===CEA,CA125,CA199检测在良恶性胸腔积液鉴别诊断中的运用（中华医学会文献）===</div></td><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>===CEA,CA125,CA199检测在良恶性胸腔积液鉴别诊断中的运用（中华医学会文献）===</div></td></tr> <tr><td class='diff-marker'>−</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>结果:[[胸腔积液]]、[[血清CEA]]、CA125和CA199水平,恶性组均都高于非恶性(P<del class="diffchange diffchange-inline">&lt;</del>0.05);恶性[[胸腔积液]]肿标含量均高于血清(P<del class="diffchange diffchange-inline">&lt;</del>0.05).</div></td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>结果:[[胸腔积液]]、[[血清CEA]]、CA125和CA199水平,恶性组均都高于非恶性(P<ins class="diffchange diffchange-inline">&amp;amp;lt;</ins>0.05);恶性[[胸腔积液]]肿标含量均高于血清(P<ins class="diffchange diffchange-inline">&amp;amp;lt;</ins>0.05).</div></td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"></td><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"></td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>===联合检测CEA、ADA、LDH及血沉对胸腔积液性质判断的临床意义（中华医学会文献）===</div></td><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>===联合检测CEA、ADA、LDH及血沉对胸腔积液性质判断的临床意义（中华医学会文献）===</div></td></tr> <!-- diff cache key mediawiki:diff:version:1.11a:oldid:227350:newid:1349001 --> </table>

KGadmin http://120.24.161.253:5617/index.php?title=%E8%83%B8%E8%85%94%E7%A7%AF%E6%B6%B2-%E5%AE%9E%E9%AA%8C%E5%AE%A4%E6%A3%80%E6%9F%A5-%E8%A1%80%E6%B8%85CEA&diff=227350&oldid=prev 2021-10-21T07:58:06Z

<p>导入1个版本</p> <table class="diff diff-contentalign-left" data-mw="interface"> <tr style="vertical-align: top;" lang="zh-CN"> <td colspan="1" style="background-color: white; color:black; text-align: center;">←上一版本</td> <td colspan="1" style="background-color: white; color:black; text-align: center;">2021年10月21日 (四) 07:58的版本</td> </tr><tr><td colspan="2" style="text-align: center;" lang="zh-CN"><div class="mw-diff-empty">（没有差异）</div> </td></tr></table>

Admin http://120.24.161.253:5617/index.php?title=%E8%83%B8%E8%85%94%E7%A7%AF%E6%B6%B2-%E5%AE%9E%E9%AA%8C%E5%AE%A4%E6%A3%80%E6%9F%A5-%E8%A1%80%E6%B8%85CEA&diff=227345&oldid=prev 2021-10-19T13:56:59Z

<p>修改1</p> <p><b>新页面</b></p><div>主实体：[[胸腔积液]]，关系：[[实验室检查]] ，尾实体：[[血清CEA]]<br /> <br /> 实体ID:''738069''<br /> ==关系介绍==<br /> 待补充<br /> <br /> ==来源==<br /> ===CEA,CA125,CA199检测在良恶性胸腔积液鉴别诊断中的运用（中华医学会文献）===<br /> 结果:[[胸腔积液]]、[[血清CEA]]、CA125和CA199水平,恶性组均都高于非恶性(P&lt;0.05);恶性[[胸腔积液]]肿标含量均高于血清(P&lt;0.05).<br /> <br /> ===联合检测CEA、ADA、LDH及血沉对胸腔积液性质判断的临床意义（中华医学会文献）===<br /> 结论 联合检测[[胸腔积液]]患者[[血清CEA]]、胸水及血清LDH,胸水ADA及血沉对辅助判断[[胸腔积液]]的性质具有重要价值.<br /> <br /> ===T-SPOT.TB、CEA和CA125测定胸腔积液的临床研究（中华医学会文献）===<br /> 2.[[胸腔积液]]/[[血清CEA]]比值越大,提示胸水的恶性可能性越大;在血清及胸水CEA正常情况下,[[胸腔积液]]/血清CA125比值大,提示胸水的结核性可能性越大.<br /> <br /> ===内科胸腔镜及体内癌胚抗原水平对恶性胸腔积液的诊断价值（中华医学会文献）===<br /> 方法 回顾性分析我院2015年8月至2016年8月期间77例[[胸腔积液]]患者的临床资料,以内科胸腔镜病理结果作为金标准,评价胸水CEA、[[血清CEA]]以及胸水/[[血清CEA]]比值对恶性[[胸腔积液]]的诊断价值.</div>

Admin